市場調查報告書
商品編碼
1547504
全球乾眼症治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測Global Dry Eye Disease Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球乾眼症治療市場需求預計將從2023年的59.9億美元達到2032年近89.4億美元的市場規模,2024-2032年研究期間複合年成長率為4.55%。
乾眼症是一個術語,定義感染者眼睛表面缺乏潤滑或水分。這是一種常見的疾病,幾乎可以影響任何人。乾眼症的症狀很多,包括疼痛和灼熱感、眼睛發紅、眼睛疲勞、眼睛發癢、畏光、眼睛酸痛、流淚等。 、吸煙、LASIK 眼科手術、荷爾蒙替代療法等。
過度使用智慧型手機和電腦、人口老化(極易患有乾眼症)以及其他風險因素正在主導乾眼症治療市場。根據《2019 年世界人口展望》估計,全球約 9% 的人口年齡在 65 歲以上,到 2050 年,這一比例預計將佔全球人口的近 17%。患有糖尿病、甲狀腺疾病、紅斑性狼瘡、硬皮症、乾燥症、類風濕性關節炎等疾病的人罹患乾眼症的風險很高。這些疾病盛行率的擴大往往會導致乾眼症發生率的上升。意識水平的提高、診斷率的提高、更好的治療選擇的可用性是促進市場成長的其他因素。然而,患者自我藥療的盛行以及對乾眼症的認知較低可能會成為市場的限制。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球乾眼症治療市場的各個細分市場進行了包容性評估。乾眼症治療產業的成長和趨勢為本研究提供了整體方法。
乾眼症治療市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲乾眼症治療市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。乾眼症治療市場的主要參與者包括諾華公司、艾爾建、Bausch Health Companies Inc.、參天製藥有限公司、OASIS Medical。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Dry Eye Disease Treatment Market is presumed to reach the market size of nearly USD 8.94 Billion by 2032 from USD 5.99 Billion in 2023 with a CAGR of 4.55% under the study period 2024-2032.
Dry eye disease is a term that defines the lack of lubrication or moisture on the surface of the infected person's eyes. It is a usually occurring disease that can affect almost anyone. Numerous dry eye symptoms include aching and burning sensations, red eyes, tired eyes, itchy eyes, photophobia, sore eyes, watery eyes, etc. Factors causing dry eye syndrome include excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.
Excessive use of smartphones & computers, expanding aging population, which is highly prone to the syndrome, and other risk factors are steering the dry eye disease treatment market. As per World Population Prospects 2019 estimates, around 9% of the global population is over 65 years of age, and by 2050 this is expected to account for nearly 17% of the worldwide population. Individuals with diseases such as diabetes, thyroid disorders, lupus, scleroderma, Sjogren's syndrome, rheumatoid arthritis are at high risk of causing dry eye disease. Expanding prevalence of these diseases will tend to cause a rise in the incidence of dry eye disease. Increasing awareness levels, rising diagnostic rates, availability of better treatment options are other factors augmenting the market's growth. However, the prevalence of self-medication by patients and low awareness about dry eye disease are likely to act as market restraints.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Dry Eye Disease Treatment. The growth and trends of Dry Eye Disease Treatment industry provide a holistic approach to this study.
This section of the Dry Eye Disease Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Dry Eye Disease Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dry Eye Disease Treatment market include Novartis AG, Allergan, Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., OASIS Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.